Biocept (BIOC) Reports Q1 Loss of $0.41

Biocept (NASDAQ: BIOC) reported Q1 EPS of ($0.41), versus $0.00 reported last year. Revenue for the quarter came in at $700 thousand versus the consensus estimate of $1.58 million.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c